Sylvan Baca MD PhD

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	12495	6424
h-endeksi	27	26
i10-endeksi	32	32

1400

700

350

1050

2012201320142015201620172018201920202021202220232024202537 238 615 885 1026 1080 1066 1020 1161 1315 1319 1172 1263 183

Genel erişim

Tümünü görüntüle

41 makale

1 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Toni ChoueiriDana-Farber Cancer Institutedfci.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Levi GarrawayAssociate Professor of Medicine, Harvard Medical Schooldfci.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Mark A RubinProfessor & Director Department for BioMedical Research, University of Berndbmr.unibe.ch üzerinde doğrulanmış e-posta adresine sahip
Alexander (Sasha) GusevDana-Farber Cancer Institutedfci.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Spisak SandorHUN-REN, Institute of Molecular Life Sciencesttk.hu üzerinde doğrulanmış e-posta adresine sahip
Himisha BeltranDana Farber Cancer Institutedfci.harvard.edu üzerinde doğrulanmış e-posta adresine sahip
Sarah Abou AlaiwiCardiology Fellow, Yale New Haven Hospitalyale.edu üzerinde doğrulanmış e-posta adresine sahip
Christopher BarbieriAssociate Professor of Urology, Weill Cornell Medicinemed.cornell.edu üzerinde doğrulanmış e-posta adresine sahip
Bogdan PasaniucProfessor at UCLAucla.edu üzerinde doğrulanmış e-posta adresine sahip
Pier Vitale NuzzoWeill Cornell Medicine, New York-Presbyterian Hospital, New York, USAmed.cornell.edu üzerinde doğrulanmış e-posta adresine sahip
Davide PrandiFondazione Bruno Kesslerfbk.eu üzerinde doğrulanmış e-posta adresine sahip
Tommer SchwarzUCLAg.ucla.edu üzerinde doğrulanmış e-posta adresine sahip
Francesca DemichelisDepartment of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Italyunitn.it üzerinde doğrulanmış e-posta adresine sahip
Andrea SbonerAssociate Professor, Department of Pathology and Laboratory Medicine, EIPM, WCMmed.cornell.edu üzerinde doğrulanmış e-posta adresine sahip
Jacqueline Fontugnecurie.fr üzerinde doğrulanmış e-posta adresine sahip
Namrata UdeshiBroad Institute of MIT and Harvardbroadinstitute.org üzerinde doğrulanmış e-posta adresine sahip
Steven A CarrBroad Institute of MIT and Harvardbroad.mit.edu üzerinde doğrulanmış e-posta adresine sahip
Anna GronerETH Zurichbsse.ethz.ch üzerinde doğrulanmış e-posta adresine sahip
Keegan KorthauerAssistant Professor, University of British Columbiastat.ubc.ca üzerinde doğrulanmış e-posta adresine sahip
Amin H. NassarYale New Haven Hospital/Yale Universityyale.edu üzerinde doğrulanmış e-posta adresine sahip

Takip et

Sylvan Baca MD PhD

Assistant Professor, Harvard Medical School

partners.org üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa

Computational epigenomics circulating biomarkers machine learning genitourinary oncology


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Mutational heterogeneity in cancer and the search for new cancer-associated genes MS Lawrence, P Stojanov, P Polak, GV Kryukov, K Cibulskis, ... Nature 499 (7457), 214-218, 2013	6096	2013
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer CE Barbieri, SC Baca, MS Lawrence, F Demichelis, M Blattner, ... Nature genetics 44 (6), 685-689, 2012	1791	2012
Punctuated evolution of prostate cancer genomes SC Baca, D Prandi, MS Lawrence, JM Mosquera, A Romanel, Y Drier, ... Cell 153 (3), 666-677, 2013	1483	2013
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma JA Perry, A Kiezun, P Tonzi, EM Van Allen, SL Carter, SC Baca, ... Proceedings of the National Academy of Sciences 111 (51), E5564-E5573, 2014	460	2014
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis AM Dulak, SE Schumacher, J Van Lieshout, Y Imamura, C Fox, B Shim, ... Cancer research 72 (17), 4383-4393, 2012	313	2012
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes PV Nuzzo, JE Berchuck, K Korthauer, S Spisak, AH Nassar, S Abou Alaiwi, ... Nature medicine 26 (7), 1041-1043, 2020	249	2020
Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer JPP Theurillat, ND Udeshi, WJ Errington, T Svinkina, SC Baca, M Pop, ... Science 346 (6205), 85-89, 2014	244	2014
Prostate cancer reactivates developmental epigenomic programs during metastatic progression MM Pomerantz, X Qiu, Y Zhu, DY Takeda, W Pan, SC Baca, A Gusev, ... Nature genetics 52 (8), 790-799, 2020	226	2020
EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer KL Morel, AV Sheahan, DL Burkhart, SC Baca, N Boufaied, Y Liu, X Qiu, ... Nature cancer 2 (4), 444-456, 2021	183	2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer SC Baca, DY Takeda, JH Seo, J Hwang, SY Ku, R Arafeh, T Arnoff, ... Nature Communications 12 (1), 1979, 2021	126	2021
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma Z Bakouny, DA Braun, SA Shukla, W Pan, X Gao, Y Hou, A Flaifel, S Tang, ... Nature communications 12 (1), 808, 2021	120	2021
Unraveling the clonal hierarchy of somatic genomic aberrations D Prandi, SC Baca, A Romanel, CE Barbieri, JM Mosquera, J Fontugne, ... Genome biology 15, 1-16, 2014	113	2014
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer P Cejas, Y Xie, A Font-Tello, K Lim, S Syamala, X Qiu, AK Tewari, N Shah, ... Nature communications 12 (1), 5775, 2021	107	2021
CDK7 inhibition suppresses castration-resistant prostate cancer through MED1 inactivation R Rasool, R Natesan, Q Deng, S Aras, P Lal, S Sander Effron, ... Cancer discovery 9 (11), 1538-1555, 2019	106	2019
ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer S Nouruzi, D Ganguli, N Tabrizian, M Kobelev, O Sivak, T Namekawa, ... Nature Communications 13 (1), 2282, 2022	85	2022
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer X Lu, K Fong, G Gritsina, F Wang, SC Baca, LT Brea, JE Berchuck, ... Nature genetics 54 (5), 670-683, 2022	72	2022
Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes SC Baca, KS Wong, KC Strickland, HT Heller, MI Kim, JA Barletta, ... Cancer Cytopathology 125 (5), 313-322, 2017	71	2017
Mammalian SWI/SNF complex genomic alterations and immune checkpoint blockade in solid tumors S Abou Alaiwi, AH Nassar, W Xie, Z Bakouny, JE Berchuck, DA Braun, ... Cancer immunology research 8 (8), 1075-1084, 2020	68	2020
Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary I Moon, J LoPiccolo, SC Baca, LM Sholl, KL Kehl, MJ Hassett, D Liu, ... Nature Medicine 29 (8), 2057-2067, 2023	59	2023
The genomic landscape of prostate cancer SC Baca, LA Garraway Frontiers in endocrinology 3, 69, 2012	59	2012

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar